Clinical Trial

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
ONO-4059-10:Multicenter, placebo-controlled, randomized, double-blind, Phase 3 study in patients with steroid-resistant pemphigus
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-21
notable Sponsor changed: Ono Pharmaceutical Co. Ltd -> Ono Pharmaceutical Co., Ltd. 2026-04-19
Trial Details
NCT Number NCT06696716
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Pemphigus, Steroid-resistant Pemphigus
Enrollment 34 participants
Start Date 2022-08-15
Primary Completion 2027-09-30 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20